News Headlines

Display #
Title
Novartis real-world data at AAN confirms benefit of Gilenya® on four key measures of disease activity in relapsing MS
2017 Healthcare Agency/Network Industry Person of the Year: Dana Maiman, President and CEO, FCB Health
Agency + Network Structure Listing: 2017
Notes & Methodology for Participating Healthcare Communications Agencies
Ahead into a cloudy future
Germany’s Fresenius Kabi Slams Down $4.3 Billion for Akorn in U.S. Expansion
AstraZeneca moving costs rise as new HQ nears completion
Beleaguered Bay Area Pharma OncoMed Lays Off Half Its Workforce
FDA takes action against 14 companies for selling illegal cancer treatments
Biogen profit beats analysts’ estimates
Novartis sets sights on return to growth in 2018
Purohit Navigation: 2017
PulseCX: 2017
Precision for Value: 2017
Precision Effect: 2017
Pixacore: 2017
Patients & Purpose: 2017
Palio: 2017
Pacific Communications: 2017
Omnicom Health Group: 2017
fastessaysonline.co.uk close-up: number one service to receive college papers speedily & with no trouble
Research moves closer to unraveling mystery cause of multiple sclerosis
Pfizer unveils ATLAS®, an interactive, user-friendly website that provides global antibiotic resistance surveillance data across 60 countries
en.akadem-ghostwriter.de analysis: top firm to acquire papers asap & easy
Essaydeutsch . De – Traditionell Seriöse Aufsatz schreiben Lösung
Lilly to present data for galcanezumab for the prevention of migraine at the American Academy of Neurology (AAN) annual meeting
Merck partners with University of California, San Diego (UCSD) to fight Neglected Tropical Diseases
Biotech firm pulls pioneering gene therapy due to no demand
Two-horse race: Auris, Otonomy seek FDA nod for inner-ear therapies
On your bike: Cycling to work linked with large health benefits